Skip to main content
. 2019 Jun 13;19:61. doi: 10.1186/s12902-019-0385-0

Fig. 3.

Fig. 3

Toxicity of insulin-derived amyloidosis in Cases 1–5. Two samples separately prepared from Case 5 (Case 5–1 and 5–2) in the HEK293T cell assay (a) and one sample (Case 5–2) in the HeLa cell assay (b) show significantly lower cell viability than the control. Error bars, SE; *, p < 0.05